XTL Biopharmaceuticals Ltd. (XTLB)
1.98
-0.01
(-0.50%)
USD |
NASDAQ |
Oct 09, 16:00
1.98
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals Max Drawdown (5Y) : 90.10% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 90.10% |
| August 31, 2026 | 90.10% |
| July 31, 2026 | 90.10% |
| June 30, 2026 | 90.10% |
| May 31, 2026 | 88.94% |
| April 30, 2026 | 88.94% |
| March 31, 2026 | 88.85% |
| February 28, 2026 | 88.85% |
| January 31, 2026 | 88.85% |
| December 31, 2025 | 88.85% |
| November 30, 2025 | 85.38% |
| October 31, 2025 | 85.38% |
| September 30, 2025 | 85.38% |
| August 31, 2025 | 85.38% |
| July 31, 2025 | 85.38% |
| June 30, 2025 | 86.30% |
| May 31, 2025 | 88.09% |
| April 30, 2025 | 89.33% |
| March 31, 2025 | 92.23% |
| February 28, 2025 | 92.62% |
| January 31, 2025 | 92.62% |
| December 31, 2024 | 92.62% |
| November 30, 2024 | 92.62% |
| October 31, 2024 | 92.62% |
| September 30, 2024 | 92.62% |
| Date | Value |
|---|---|
| August 31, 2024 | 92.62% |
| July 31, 2024 | 92.62% |
| June 30, 2024 | 92.62% |
| May 31, 2024 | 92.62% |
| April 30, 2024 | 92.62% |
| March 31, 2024 | 92.62% |
| February 29, 2024 | 92.62% |
| January 31, 2024 | 92.62% |
| December 31, 2023 | 93.05% |
| November 30, 2023 | 94.22% |
| October 31, 2023 | 94.22% |
| September 30, 2023 | 94.22% |
| August 31, 2023 | 94.22% |
| July 31, 2023 | 94.93% |
| June 30, 2023 | 95.14% |
| May 31, 2023 | 95.14% |
| April 30, 2023 | 95.57% |
| March 31, 2023 | 95.57% |
| February 28, 2023 | 95.57% |
| January 31, 2023 | 95.57% |
| December 31, 2022 | 95.57% |
| November 30, 2022 | 95.57% |
| October 31, 2022 | 95.57% |
| September 30, 2022 | 95.57% |
| August 31, 2022 | 95.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| BioLineRx Ltd. | 98.88% |
| Kamada Ltd. | 67.69% |
| Can-Fite BioPharma Ltd. | 99.50% |
| Eocene Ltd. | 99.94% |
| Revium Recovery, Inc. | 98.64% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -50.88 |
| Beta (5Y) | 1.371 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 114.9% |
| Historical Sharpe Ratio (5Y) | -0.3235 |
| Historical Sortino (5Y) | -1.260 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 26.35% |